Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05495256Not ApplicableCompleted

Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.

Role: lead

NCT04417842Completed

Connect Lung Outcomes With Bronchodilator Use

Role: lead

NCT04926077Not ApplicableCompleted

DreamKit Respiratory Effort Signal Validation

Role: collaborator

NCT04630639Not ApplicableWithdrawn

Sparkle Respiratory Effort Validation

Role: collaborator

NCT03219749Not ApplicableCompleted

Sleep Apnea, Cardiovascular and Exercise Study

Role: collaborator

All 5 trials loaded